Covovax nod to strengthen immunization efforts in India: SII
Vaccine major serum institute of India (SII) on Tuesday said the approval for the covid-19 vaccine 'covovax' would strength immunization across India and various lower and middle income countries (LMIC's) across the world.
"The approval of Covovax by DCGI is a significant milestone in strengthening our immunization efforts across india and LMIC's. We are proud to deliver a highly-effective protein-based COVID-19 vaccine of more than 90 per dent efficacy rate, based on clinical data demonstrating a favorable safty profile. we are certain that as the repertoire of the COVID-19 vaccine increases, we will be poised strongly to save the lives of millions of people against the pandemic, " SII CEO adar poonawalla said the the statement.
For more details, check out the full story on the link below: